• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/155 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/155

Total number of patents in this class: 373

10-year publication summary

48
26
29
31
25
16
29
14
18
7
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The Regents of the University of California
19898
10
Bristol-myers Squibb Company
4878
9
Boehringer Ingelheim International GmbH
4656
6
Duke University
3064
6
Janssen Pharmaceutica N.V.
3395
5
Abbott Laboratories
2402
5
Amyris, Inc.
372
5
Aurimmed Pharma, Inc.
7
5
CHDI Foundation, Inc.
108
5
The Cooper Health System
38
5
Nerviano Medical Sciences S.r.l.
256
5
Tetraphase Pharmaceuticals, Inc.
51
5
VALO Health, Inc.
172
5
Centre National de La Recherche Scientifique
10421
4
President and Fellows of Harvard College
5975
4
Abbvie Inc.
1802
4
Arena Pharmaceuticals, Inc.
366
4
Genfit
270
4
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
75
4
Intervet Inc.
905
4
Other owners 269